Opaleye Management’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,400
Closed -$441K 45
2024
Q2
$441K Sell
50,400
-14,800
-23% -$130K 0.1% 50
2024
Q1
$1.6M Buy
65,200
+13,320
+26% +$326K 0.35% 41
2023
Q4
$861K Buy
+51,880
New +$861K 0.23% 45